Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2013

  Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference
  and Date of Fourth Quarter and Full Year 2013 Financial Results

JPMorgan Healthcare Conference 2014

Business Wire

BOSTON -- January 7, 2014

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it
will webcast its corporate presentation at the 32^nd Annual J.P. Morgan
Healthcare Conference on Tuesday, January 14 at 11:30 a.m. ET. The audio
portion of the remarks may be accessed live through Vertex’s website at
www.vrtx.com in the “Investors” section under “Events and Presentations”.

In addition, the company announced today that it will report its fourth
quarter and full year 2013 financial results on Wednesday, January 29 after
the markets close. In conjunction with the announcement, management will host
a conference call that day at 5:00 p.m. ET. To participate in the conference
call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).
The call will also be available as a live and archived webcast on Vertex's
website at www.vrtx.com in the “Investors” section under “Events and
Presentations”.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and
commercialize innovative medicines so people with serious diseases can lead
better lives. Vertex scientists and our collaborators are working on new
medicines to cure or significantly advance the treatment of cystic fibrosis,
hepatitis C, rheumatoid arthritis and other life-threatening diseases. In
addition to our clinical development programs, Vertex has more than a dozen
ongoing preclinical programs aimed at other serious and life-threatening
diseases.

Founded in 1989 in Massachusetts, Vertex today has research and development
sites and commercial offices in the United States, Europe, Canada and
Australia. For four years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences. For additional information and the
latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

Contact:

Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530
 
Press spacebar to pause and continue. Press esc to stop.